Suven Pharma Q2 results: Net profit up 10% YoY to Rs 79.5 crore – Copy 03 01/202410 11/2023 by admin-suven
PE firm Advent acquires 50.1% stake in Suven Pharma at Rs 495/share, to make open offer for additional 26% stake 29 09/2023 by admin-suven
Cabinet okays FDI of up to Rs 9,589 crore for 76.1% stake in Hyderabad-based Suven Pharma 29 09/2023 by admin-suven